더블유에스아이

299170KOSDAQ생활용품 도매업

44.3 / 100

Reference Date: 2026-06-10

Financial Score11.0 / 40

News Sentiment21.3 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Plunged 29.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Double WSI is expanding its business beyond spine and joint medical device distribution by developing surgical assist robots and acquiring pharmaceutical companies. The company is creating vertical and horizontal synergies through a three-pronged business model (distribution-pharmaceuticals-medical robots), having acquired a pharmaceutical firm, Introvapharma, and a clinical trial analysis company, IBP Lab, to grow into a comprehensive healthcare enterprise.

Number of Employees

29people

Average Salary

47.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 10.954.0Point

PBR

1.01Industry Average 0.661.0Point

1.5x industry avg (risky)

ROE

-6.45Industry Average 0.060.0Point

Well below industry avg

Debt Ratio

25.79Industry Average 11.050.0Point

2.3x industry avg (risky)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲29.4% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲8.4% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 1.2% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
이지메디봇, 선천성 소아심장기형 의료기기 '코나-엠에프' 식약처 허.....
더블유에스아이 자회사 이지메디봇의 혁신 의료기기 '코나-엠에프'가 식품의약품안전처로부터 허가를 받아 시장 경쟁력 강화 기대.
Positive
이지메디봇, 식약처 주관 혁신의료기기 기술지원 사업 선정
더블유에스아이 자회사 이지메디봇의 혁신의료기기 선정으로 기업의 기술력과 성장 가능성이 높아져 긍정적 영향 기대.
Positive
인트로바이오파마, 경구용 세마글루타이드 흡수 기술 확보
인트로바이오파마의 경구용 세마글루타이드 흡수 기술 확보로 더블유에스아이 관련 자회사의 신약 및 제네릭 시장 진출이 가속화되어 긍정적 영향 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 1,519Won52-week high 4,18052-week low 1,460

1-month return0.0Point

1m -29.84% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral[기재정정]주식등의대량보유상황보고서(일반)2026-06-02
Neutral주식등의대량보유상황보고서(일반)2026-05-29
Neutral분기보고서 (2026.03)2026-05-15